nejm semaglutide heart failure VisualAbstract: improves symptoms in patients with SELECT Trial

Pathological scarring: strategic interventions

Comparing discontinuation outcomes across GLP-1 medications Not all GLP-1 medications are equal when it comes to what happens after stopping

If you can drive down blood sugar, then you don't need as much insulin to control it. The Benefits Improved Blood Sugar SGLT-2 inhibitors can improve A1C by 0.20 to 0.45 percentage points while also improving time in range

It could enhance collagen synthesis and fibroblast activity, both essential to tissue repair

A 1992 study by Hartman et al

Emerging evidence provided insight into the role of signal transducer and activator of transcription 3 (STAT3) in energy metabolism